跳至主要内容
临床试验/NL-OMON48812
NL-OMON48812已完成不适用

The effect of rectal swab culture-guided antimicrobial prophylaxis in men undergoing prostate biopsy on infectious complications and cost of care: A randomized controlled trial in the Netherlands. - PRO-SWAP

Radboud Universitair Medisch Centrum0 个研究点目标入组 1,538 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,538

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Subject undergoes a transrectal prostate biopsy as part of the standard care
  • in one of the participating (study) centers (because of suspicion of prostate
  • - Subject is able and willing to sign the Informed Consent Form.

排除标准

  • - Inability to receive ciprofloxacin prophylaxis for any reason (e.g.
  • documented history of sensitivity to medicinal products or excipients similar
  • to those found in the antibiotic prophylaxis, relevant history or presence of
  • cardiovascular disorders (specific relevant QTc time prolongation), relevant
  • drug interaction).
  • - Inability to receive either co-trimoxazole, fosfomycin and
  • pivmecillinam/augmentin prophylaxis for any reason (e.g. documented history of
  • sensitivity to medicinal products or excipients similar to those found in the
  • antibiotic prophylaxis, relevant drug interaction).
  • - Inability to understand the nature of the trial and the procedures required.
  • - Individuals with an urinary tract infection or acute prostatitis within 14
  • days prior to transrectal prostate biopsy.
  • - Individuals who received antibiotics within 14 days prior to transrectal
  • prostate biopsy.
  • - Individuals who fail to send a rectum swab to the microbiology laboratory.
  • - Individuals whose rectal swab shows no growth on a Colombia blood agar (CBP)
  • (growth control)

研究者

相似试验